MedTrace Logo

Chemotherapy Induced Neuropathy in Cancer Patients

NCT06491082 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 124

Last updated 2024-07-08

No results posted yet for this study

Summary

The purpose of this prospective study is to perform Nerve conduction test, Vitamin D, Vitamin B12 and NADPH oxidase 4(NOX4) expression to assess severity of chemotherapy induced Peripheral neuropathy (CIPN) in solid cancer (Head and Neck, Breast, Prostate) patients who planned for at least 4 cycle of chemotherapy in different nutrient status level and gene expression.

Conditions

  • Chemotherapy-induced Peripheral Neuropathy

Interventions

DRUG

Cisplatin, Carboplatin, Paclitaxel, Docetaxel

Solid cancer Patients receiving any one drug or in combination

Sponsors & Collaborators

  • Swami Rama Himalayan University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-11-23
Primary Completion
2024-08-20
Completion
2024-08-25
FDA Drug
Yes

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06491082 on ClinicalTrials.gov